Axsome Therapeutics, Inc. (AXSM) › Total AssetsAxsome Therapeutics, Inc. (AXSM) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $49.08M2016: $38.21M2017: $35.56M2018: $15.38M2019: $220.55M2020: $186.13M2021: $87.79M2022: $331.48M2023: $588.24M2024: $568.50M2025: $689.80M$689.80M2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$689.80M+21.3%2024$568.50M-3.4%2023$588.24M+77.5%2022$331.48M+277.6%2021$87.79M-52.8%2020$186.13M-15.6%2019$220.55M+1334.1%2018$15.38M-56.7%2017$35.56M-7.0%2016$38.21M-22.1%2015$49.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share